Xi Su

1.2k total citations
28 papers, 454 citations indexed

About

Xi Su is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xi Su has authored 28 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xi Su's work include Thyroid Cancer Diagnosis and Treatment (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related Molecular Pathways (3 papers). Xi Su is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related Molecular Pathways (3 papers). Xi Su collaborates with scholars based in China, United States and Hong Kong. Xi Su's co-authors include Peng Hou, Meiju Ji, Fang Sui, Qi Yang, Demao Yao, Jingjing Ma, Zhen Shen, Jun Pu, Simeng Wang and Jia Hao and has published in prestigious journals such as ACS Nano, Cell Death and Differentiation and Anesthesiology.

In The Last Decade

Xi Su

25 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xi Su China	12	229	101	78	55	55	28	454
Bryan Ngo United States	11	331 1.4×	88 0.9×	111 1.4×	106 1.9×	153 2.8×	15	627
Yung‐Lung Chang Taiwan	15	360 1.6×	104 1.0×	71 0.9×	37 0.7×	19 0.3×	32	566
Manuela Oraldi Italy	13	265 1.2×	165 1.6×	149 1.9×	40 0.7×	86 1.6×	16	606
Yuqing Zhang China	8	216 0.9×	67 0.7×	131 1.7×	31 0.6×	13 0.2×	14	479
Arisa Imsumran Thailand	15	295 1.3×	157 1.6×	168 2.2×	62 1.1×	29 0.5×	26	581
Zhihua Yang China	14	241 1.1×	106 1.0×	134 1.7×	30 0.5×	23 0.4×	34	521
F. C. Campos Brazil	8	187 0.8×	78 0.8×	133 1.7×	39 0.7×	28 0.5×	11	480
Yonghui Dong China	12	335 1.5×	60 0.6×	134 1.7×	37 0.7×	12 0.2×	21	577
Marian Raschke Germany	11	170 0.7×	42 0.4×	85 1.1×	101 1.8×	30 0.5×	25	479

Countries citing papers authored by Xi Su

Since Specialization

Citations

This map shows the geographic impact of Xi Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Su more than expected).

Fields of papers citing papers by Xi Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Su. The network helps show where Xi Su may publish in the future.

Co-authorship network of co-authors of Xi Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Su. A scholar is included among the top collaborators of Xi Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Su. Xi Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tian, Wenzhi, et al.. (2025). Ferroptosis in thyroid cancer: mechanisms, current status, and treatment. Frontiers in Oncology. 15. 1495617–1495617.

Chen, Dong, Huihui Yang, Lei Zhang, et al.. (2025). Endocrine cancer organoids in basic and translational medical research. Science China Life Sciences. 68(10). 2842–2866.

Zhang, Xin, Shulin Zhao, Xi Su, & Lifeng Xu. (2024). From docking to dynamics: Unveiling the potential non-peptide and non-covalent inhibitors of Mpro from natural products. Computers in Biology and Medicine. 181. 108963–108963. 2 indexed citations

Qiao, Liang, Xiaojing Han, Lulu Xiao, et al.. (2024). Npc1 deficiency impairs microglia function via TREM2-mTOR signaling in Niemann-Pick disease type C. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167478–167478. 2 indexed citations

Zeng, Ya, Xi Su, Jingyi Jia, et al.. (2024). Propensity-matched study on locally advanced esophageal cancer: surgery versus post-operative radiotherapy. Radiation Oncology. 19(1). 130–130. 1 indexed citations

Yu, Kaiwen, et al.. (2024). <italic>EEPD1</italic> attenuates radiation-induced cardiac hypertrophy and apoptosis by degrading <italic>FOXO3A</italic> in cardiomyocytes. Acta Biochimica et Biophysica Sinica. 56(12). 1733–1747. 2 indexed citations

Su, Xi, Dong Chen, Jia Hao, et al.. (2022). SGSM2 inhibits thyroid cancer progression by activating RAP1 and enhancing competitive RAS inhibition. Cell Death and Disease. 13(3). 218–218. 12 indexed citations

Su, Xi, Peng Li, Bin Han, et al.. (2021). Vitamin C sensitizes BRAFV600E thyroid cancer to PLX4032 via inhibiting the feedback activation of MAPK/ERK signal by PLX4032. Journal of Experimental & Clinical Cancer Research. 40(1). 34–34. 22 indexed citations

Su, Xi, Chao Feng, Simeng Wang, et al.. (2021). The noncoding RNAs SNORD50A and SNORD50B-mediated TRIM21-GMPS interaction promotes the growth of p53 wild-type breast cancers by degrading p53. Cell Death and Differentiation. 28(8). 2450–2464. 40 indexed citations

10.

Su, Xi, Jiaxin Liu, Haihong Zhang, et al.. (2020). <p>Lenvatinib Promotes the Antitumor Effect of Doxorubicin in Anaplastic Thyroid Cancer</p>. OncoTargets and Therapy. Volume 13. 11183–11192. 10 indexed citations

11.

Su, Xi, Chao Feng, Siyu Liu, et al.. (2020). CYP2S1 is a synthetic lethal target in BRAFV600E-driven thyroid cancers. Signal Transduction and Targeted Therapy. 5(1). 191–191. 14 indexed citations

12.

Su, Wilber, et al.. (2020). Minimal dose of cryoballoon ablation leading to atrioesophageal fistula formation. HeartRhythm Case Reports. 7(3). 148–149. 1 indexed citations

13.

Lau, King Wai, et al.. (2018). Bioinformatics-based identification of differentiated expressed microRNA in esophageal squamous cell carcinoma. Translational Cancer Research. 7(6). 1366–1375. 4 indexed citations

14.

Sui, Fang, Xi Su, Pu Chen, et al.. (2018). Gender-related differences in the association between concomitant amplification of AIB1 and HER2 and clinical outcomes in glioma patients. Pathology - Research and Practice. 214(9). 1253–1259. 10 indexed citations

15.

Asano, Taku, Qinhua Jin, Yuki Katagiri, et al.. (2018). A randomised comparison of healing response between the BuMA Supreme stent and the XIENCE stent at one-month and two-month follow-up: PIONEER-II OCT randomised controlled trial. EuroIntervention. 14(12). e1306–e1315. 9 indexed citations

16.

He, Wangxiao, Jin Yan, Fang Sui, et al.. (2018). Turning a Luffa Protein into a Self-Assembled Biodegradable Nanoplatform for Multitargeted Cancer Therapy. ACS Nano. 12(11). 11664–11677. 46 indexed citations

17.

Han, Yaling, Haiwei Liu, Yuejin Yang, et al.. (2017). A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study. EuroIntervention. 13(10). 1210–1217. 12 indexed citations

18.

Wang, Na, Fang Sui, Jingjing Ma, et al.. (2016). Site-specific Hypermethylation of RUNX3 Predicts Poor Prognosis in Gastric Cancer. Archives of Medical Research. 47(4). 285–292. 16 indexed citations

19.

Su, Xi. (2015). Theoretical analysis of internal heat caused by taking ginseng. Zhonghua zhongyiyao zazhi. 2 indexed citations

20.

Su, Xi. (2006). Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact